chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient received her 4 month vaccines (PENTACEL - (DTaP-Hib-IPV), PREVNAR 13 (pneumococcal 13 Conj) and Rotavirus oral vaccine) on 1/12/12 around 12 noon. On 1/13/12 at 1022 our office received a call from Dad stating patient stopped breathing at daycare, 911 called. At 1652 on 1/13/12 the coroner called to report her death.
This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 30-year-old male patient received BNT162b2 (BNT162B2), solution for injection, on 28Oct2021 as dose number unknown, single (Batch/Lot number: unknown) at the age of 30 years, in left arm for Covid-19 immunisation. The patient's relevant medical history included: "Asthma" (unspecified if ongoing); "seasonal allergies" (unspecified if ongoing), notes: known allergies: seasonal allergies; "Tree nuts" (unspecified if ongoing), notes: known allergies: Tree nuts. Concomitant medication(s) included: BREO ELLIPTA taken for asthma. The following information was reported: DRUG INEFFECTIVE (medically significant) with onset 12Apr2022, outcome "unknown", COVID-19 (medically significant) with onset 12Apr2022, outcome "recovering" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (12Apr2022) Positive; (Apr2022) faint positive line, notes: rapid COVID test; (Apr2022) fainter line; (20Apr2022) positive. Therapeutic measures were taken as a result of drug ineffective, Covid-19. Additional information: adverse event Tested positive for COVID on 12Apr. Prescribed Paxlovid for COVID because of been at risk from asthma. Took for 5 days. Starting 13Apr ending 18Apr. Felt mostly better by the third day of Paxlovid. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
sudden onset of shortness of breath that started 03/02/2021, taken to ER
01/01/23 presents to ED for "chest pain, fever, cough". PMHx of "HLD, ulcerative colitis, former tobacco use"
Pt presented with acute hypoxic respiratory failure secondary to covid. Treated with remdesivir and dexamethasone and rocephin and zithromax. Lasix given for mild fluid overload. Pt discharged home.
I crashed 4 minutes after the injection of the covid pfizer vaccine. I was taken by ambulance to the hospital and was put in critical care unit. I stayed in the hospital 8 days after I crashed and went CODE BLUE.
Headache; arm pain; mild nausea; This case was reported by a consumer and described the occurrence of headache in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced headache, pain in arm and nausea. On an unknown date, the outcome of the headache, pain in arm and nausea were unknown.   It was unknown if the reporter considered the headache, pain in arm and nausea to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The age group was not reported but it was selected as adult as per the vaccine indication. The patient received Shingrix and had headache, pain in arm and nausea. The reporter asked could take Motrin to treat side effects of shingrix.
He is a 2-month-old male, who comes in today accompanied by his mother who notes that he has had worsening congestion, wheezing across the past 3 weeks. She took him to the emergency room this morning and they performed x-ray and nebulizer treatment. X-ray was negative. Nebulizer improved symptoms. He was instructed to follow up with primary care, so she brought him here. She reports that he has had stiffness and congestion ever since he was born. He has had cough more recently with increase in nasal secretions. No fever.
pt states about 2 days post vax noted erythema @ inj site;erythema has progressively gotten larger;today 30OCT96 erythema measures 5"x6.5" & hot to touch;no c/o tenderness but c/o feeling achy all over-cellulitis rx w/ATB;
Itching (assumed it was a mosquito bite) was not a mosquito bite. Next morning itching persisted. Area had begun to swell, looks like a bump. By noon, area was still itchy and had turn a pinkish red color, bump is still visible into the evening.
This spontaneous report as received from a other health professional refers to unspecified number of patient of unknown age and gender. Licensed nurse reported that since 17-JUL-2014, improperly stored (Merck) VARIVAX (dose, strength, route and lot number were not reported) was dispensed to patients. No adverse effects were noted. Follow up information has been received from Licensed Practical Nurse. Nurse did not have the information (patient identifiers, lot number, expiration date or dates of vaccine administration) available. Follow up information has been received from Licensed Practical Nurse referring to a 12 month old patient of unknown gender. On 19-AUG-2014 the patient was vaccinated with improperly stored (Merck) VARIVAX lot # J013905, expiration date 30-OCT-2015. This is one of several reports received from the same reporter. Additional information is not expected because all follow ups requested to complete the case were received.
Vaccines given on 3/18/08 with no problems.  Mother brought child back to the health dept on 3/19/08 because child awakened with itching & redness on face with swollen eye lids.  Rash on no other part of body.  Mother gave benadryl at home with no improvement.
Lymph nodes swelling under arm; Tired; Headache; Feeling tight; This is a spontaneous report from a contactable consumer (patient herself). A 65-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Lot number was not reported), via an unspecified route of administration on 15Feb2021 as dose number unknown, single for COVID-19 immunisation (at the age of 65-year-old). The patient medical history and concomitant medications were not reported. On an unspecified date, the patient took the shot and like he has lymph nodes under his arm, he was feeling tight. He had a headache that went away, but he has the lymph nodes swelling under his arm and he was still a little tired. The outcome of the events lymph nodes swelling under arm and feeling tight was unknown. The outcome of the event tired was not recovered. The outcome of the event headache was recovered.  Information about Batch/Lot number has been requested.  Follow-up (12May2021): Follow-up attempts completed. No further information expected.
5 hours after the second vaccine. nausea and headache which lasted until around 12 hours.  About 21 hours after the second vaccine I got chills and shortly after that a fever that spoke to 101.8. Lasting roughly 24 hours on and off.
Two days after I received my second shot, I noticed a rash on my stomach and chest. Slowly over the next week it spread all over my body. It itched a little but nothing too severe. After two weeks, the itching was worse and the rash spread inside my ears so I began to take a prescription. It's been three weeks since the rash first appeared and it hasn't gone away yet but it does appear to be healing. My skin now feels sore, similar to a sunburn. It doesn't itch anymore, but it can be painful. My skin seems to be drying up and getting flakey, which hopefully is a sign that it's healing.
Hospitalization for covid symptoms on dates 6/27/22- 6/30/22.  Treated with ascorbic acid 1000mg daily, Vitamin D3  25 mcg daily, zinc sulfate 50mg daily.
After 15 minutes of sitting in the waiting area in case of adverse effects, (which I didn't have any) I went outside and sat in the parking lot for another 10 min. After no side effects, I drove away.  Only to have a sudden reaction as I was driving.  I've felt dizzy with flu vaccines before and have felt the same symptoms as with the covid vaccine when IV dye was injected for a CT scan 5 months ago.  Felt faint/ dizzy, Got severe tachycardia, thought my heart was gonna explode.  I drove back in a hurry, scared and confused. I was waiting to be seen, and no one ever came out.  Symptoms subsided on their own after 15 min, therefore I just left without notifying anyone.  2 hours after vaccine, my arm looked moderately red and swollen, with minimal pain.  7 hours after getting the vaccine I started with chills and body aches.  8 hours after getting the vaccine I felt feverish and malaise.  After taking Tylenol with feverish symptoms (didn't check temp) slept for 2 hours and felt a little better.
C/o widespread itching, redness of face and arms, C/o HA, nausea, abdominal cramping, tingling lips sled medicated with 25 mg BENADRYL. Patient was told to go to E.R. immediately. She contacted a physician that was a friend. She took her to her home and gave her some BENADRYL and observed her overnight.
Greater than 12 hours after initial vial puncture; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Greater than 12 hours after initial vial puncture) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017E21A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Aug-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Greater than 12 hours after initial vial puncture). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Greater than 12 hours after initial vial puncture) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   No concurrent and treatment medication was reported by patient.  The patient received their vaccine at least 4 hours past expiration, After each withdrawal the vial was put back in the fridge.
Severe crying for several days starting hours after Hib and PREVNAR. Hasn't slept for more than 1 hr at a time. Previously happy and easy.
PREGNANT; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (PREGNANT) in a 37-year-old female patient (gravida 4, para 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039K20A and 029K20A) for COVID-19 vaccination.     Patient had prior use of nicotine. No known allergies were reported.  The patient's past medical history included Alcohol use (occasional) from 1998 to 2019, Marijuana use (Rarely), Spontaneous abortion (on 2017 and 2008 (very early ectopic no intervention needed)) and Live birth on 29-Apr-2020.   On 24-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. The patient's last menstrual period was on 20-Oct-2020 and the estimated date of delivery was 27-Jul-2021. On an unknown date, the patient experienced EXPOSURE DURING PREGNANCY (PREGNANT). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  ninth week of the pregnancy.  At the time of the report, EXPOSURE DURING PREGNANCY (PREGNANT) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 14-Apr-2021, Blood glucose: normal. On 14-Apr-2021, Ultrasound scan: normal.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   concomitant medication was not provided.  Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 23-Apr-2021: Followup information was received on 23-Apr-2021: Pregnancy dates (Date of LMP, delivery expected date) added, para and gravida added with previous pregnancy details.; Reporter's Comments: This is a case of vaccine exposure during pregnancy with no associated AEs for this female. Patient will continue to be contacted for further monitoring of AEs during the pregnancy
approximately 20 minutes after patient received the vaccine and had left our clinic, she called me stating she had a hard time swallowing, felt a tightness in her chest , and also felt itchy all over asking what to do. I told her to get to the Emergency Dept right away.
pt recv vax 17AUG95 & 26AUG95 devel fever, which resolved on its own;28AUG95 pt devel a macular-papular rash on trunk & face & erythema on hand, forehead & ear;majority of lesions were petechial & there were areas of purpura;
Sore arm; fatigue; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. An elderly female patient (not pregnant) received BNT162b2 (BNT162B2), on 14Apr2021 as dose 1, single (Lot number: EW0153), in left arm for covid-19 immunisation. The patient's relevant medical history included: "high blood pressure" (unspecified if ongoing); "high cholesterol" (unspecified if ongoing); "brain aneurysm" (unspecified if ongoing). The patient took concomitant medications. Past drug history included: Known allergies: sensitive to aspirin, reaction(s): "Drug allergy"; Known allergies: sensitive to ibuprofen, reaction(s): "Drug allergy". The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "Sore arm"; FATIGUE (non-serious), outcome "unknown".  No follow-up attempts are possible. No further information is expected.
This spontaneous report as received from a patient's mother refers to a 11 years old female patient who on an unknown date was improperly vaccinated with the 3rd dose of GARDASIL (dose, route and lot # not reported). No other co-suspects were reported. No concomitant medications were reported. The reporter stated that the patient was given the vaccine a month earlier outside of the recommended specification from the Pl. The patient did not seek medical attention. Additional information is not expected.
Patient called on 10/18/17, said her arm starting hurting on 10/17/17. The shot was given on 10/16/17. Her arm was red and swollen. She had a colonoscopy done on 10/17/17, so while she was there she asked the MD about her arm, she said he looked at it and advised her to put a hot pack on it. She said she had been doing that, and it had helped the swelling and redness somewhat. She did say it was better than it was a day ago, but still a little red and swollen.
Local reaction followed by fatigue, myalgias, arthralgias, headache, fever. Then developed diarrhea and abdominal pain. Then developed numbness, tingling of extremities and dyspnea. Seen in office 3 times and ER at least once.
received less than a full dose of MMR II; administered this dose routinely only withdraws and administers 0.5ml of MMR II instead of all contents as directed in the prescribing information so they believe less than full dose given; Information has been received from a nurse referring to a child patient of unknown gender. Information about concurrent condition, concomitant medication, drug reactions/allergies and medical history was not provided.  On an unknown date, the patient was vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II) (subcutaneous; strength, dose, lot# and expiration date were not reported) for prophylaxis. Other suspect therapies included sterile diluent (Merck manufactured) (subcutaneous; strength, dose, lot#, expiration date and indication were not reported).    The nurse confirmed at least one patient received less than a full dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) (Accidental underdose). The unspecified child "moved" and some of the dose "might have squirted out". The reporter reported the unspecified nurse in the practice that administered this dose routinely only withdrawn and administered 0.5ml of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) instead of all contents as directed in the prescribing information so they believe less than full dose was given (Incorrect dose administered).  This is one of two reports which have the same reporter.; Sender's Comments:  US-009507513-1906USA009439:
No additional AE reported.; patient who received GARDASIL 9 outside of the recommended dosing schedule. Patient first dose was 11/22/2023, second dose 1/23/2023 and third dose 3/23/2023; This spontaneous report has been received from a medical assistant referring a male patient of unknown age. The patient's pertinent medical history, drug reactions, allergies and concomitant medications were not reported.  On 22-NOV-2022 (conflicting information, also reported as 22-NOV-2023), the patient was vaccinated with the first dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) injection, the second dose on 23-JAN-2023 and the third dose on 23-MAR-2023 (strengths, specific dosages, routes of administration, anatomical sites of application, lot numbers and expiration dates were not provided) (inappropriate schedule of product administration). No additional adverse event reported.
Drowsiness, dizziness starting within 30 minutes of vaccine and lasting approx 24 hours.
PATIENT SAID SHE FELT A LITTLE TINGLING AND ITCHY AT THE INJECTION SITE. BUT IT WENT AWAY AFTER 15 MINUTES LATER.
Narrative: Product Issue: (1) Patient received Influenza, Quadrivalent, Adjuvanted (Fluad) vaccine (Lot 346389; Exp 6/21/2023) on 10/21/2022. During vaccine administration the vaccine liquid came out at the head of they syringe and not the needle. Top of the syringe reportedly spins freely. Staff confirmed that the needle was all the way on the prefilled syringe. Event required wasting of flu vaccine and 2nd stick of patient. (2) A similar incident occurred 11/3/2022 involving influenza vaccine administrating to an employee. This 2nd incident occurred on 11/3/2022 and involved Afluria Quad 2022-2023 influenza vaccine also manufactured by Sequirs. NDC 33332-322-03; Lot: AS3619B; Exp: 5/31/2023. The employee reported to employee health and the vaccine was prepared for administration by attaching the needle to the prefilled syringe using the luer-lock tip. Staff administered the injection into the left deltoid and pushed the vaccine into the arm using plunger. When preparing to remove the needle, the luer-lock tip and needle remained in the employee's arm. Special care by Employee Health staff  had been taken to ensure the needle had been securely  fastened to the syringe, as the Health Promotion Coordinator had notified staff that there were other nurses who had experienced this same type issues. Per reporter in system, this is the third incident of the luer-lock tip disconnecting from the flu vaccine syringe during medication administration. **neither the employee nor the patient suffered side effects, required treatment, or had negative outcomes*
Worsen neuropathic symptoms- pains on fingers, wrists, feet, toes, back.; migraine headache; Sore arm; fatigue; This is a spontaneous report received from a contactable consumer (patient herself). A 43-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection) via an unspecified route of administration in left arm on 03Mar2021 at 11:00 at single dose for COVID-19 immunization. Medical history included ovarian cancer, Blood clots, Hypertension and Sulfa: Allergies. Concomitant medications included duloxetine hydrochloride (CYMBALTA) 30 mg; warfarin 1mg and hydrochlorothiazide. On 03Mar2021, the patient experienced sore arm, Worsen neuropathic symptoms (existing side effects from chemo) - pains on fingers, wrists, feet, toes, back (medically significant), fatigue, migrain headache for 15 days after the first dose. No treatment received for AE. The outcome of events was not recovered.  Information about lot/batch number has been requested.
Chills; Low grade fever; Dizziness; joint and muscle aches; joint and muscle aches; Weakness; This is a spontaneous report from a contactable consumer (reported for himself). A 77-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot Number: EL9264/Batch number was not reported; Expiration Date: on an unspecified date in May2021), dose 2 via an unspecified route of administration, administered in arm left on 19Feb2021 (at the age of 77-years-old) as dose 2, single for covid-19 immunisation. Medical history included glucose tolerance impaired from an unknown date and unknown if ongoing (diagnosed 10 years) and sleep apnoea syndrome from an unknown date and unknown if ongoing (diagnosed 10-12 years ago). The patient's concomitant medications were not reported. The patient previously received first dose bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot Number: EN5318/Batch number was not reported; Expiration Date: on an unspecified date in May2021), dose 2 via an unspecified route of administration, administered in arm left on 28Jan2021 (at the age of 77-years-old) as dose 2, single for covid-19 immunisation. On 20Feb2021, chills, low grade fever, dizziness, joint and muscle aches and weakness. The patient underwent lab tests and procedures which included body temperature: low on 20Feb2021. The outcome of the events chills, low grade fever was resolved on 20Feb2021, joint and muscle aches, weakness was resolved on 21Feb2021 and dizziness was resolving.  Follow-up attempts are completed. No further information is expected.
I just feel very heavy legs; It's like in waves, it comes and goes; experiencing weight, tingling; It's like in waves, it comes and goes; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 45 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 10Aug2021 15:00 (Batch/Lot number: unknown) at the age of 45 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: LIMB DISCOMFORT (non-serious) with onset 12Aug2021, outcome "unknown", described as "I just feel very heavy legs; It's like in waves, it comes and goes"; PARAESTHESIA (non-serious) with onset 2021, outcome "unknown", described as "experiencing weight, tingling; It's like in waves, it comes and goes". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of limb discomfort, paraesthesia.  Additional information: Consumer got Covid vaccine 2 days ago and the patient just feel very heavy legs, I just want to know if it's normal. Consumer stated, " I believe the LOT # is FC3181. The patient experiencied weight, tingling, heavy legs and I want to know if it's normal or not."   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Pt underwent 15 minutes observation and felt fine during that time, while walking back to work on the way to work unit noticed tingling on the L side of her lower lip and a few inches back along jaw.  It persisted so she returned to the vaccine clinic for evaluation.  She was evaluated by a physician and had a normal cranial nerve and motor exam other than diminished sensation CN5- no change in appearance of lip.  There was no other reaction at vaccination site or change in symptoms during a further 30 minute observation period.  She was released back to work.  Checkin after a few hours the tingling had improved.
A caller reported that her niece has been "really sick" since receiving Rota Shield. No further information was available at the date of this report.